Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q1 2022 · 10-Q
Revenue$596.20M$596.20M+16.4% vs Q1 2021 Net Income$12.20M$12.20MN/M vs Q1 2021 EPS Diluted$0.14$0.14N/M vs Q1 2021 Operating Income$100,400,000+56.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
Free Cash Flowderived$61,600,000+72.5% Margins · derivedOperating margin16.8%+4.3 pt vs Q1 2021
Net margin2.0%+6.1 pt vs Q1 2021
ended Mar 31, 2022 · filed May 3, 2022 · 33 d after period end